Clinical trials
Phase 3 Kidney Diseases trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 6 |
| Recruiting | 5 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Novartis Pharmaceuticals | 3 |
| Bayer | 2 |
| Eli Lilly and Company | 2 |
| University Hospital, Tours | 2 |
| Amgen | 1 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 1 |
| Dimerix Bioscience Pty Ltd | 1 |
| Human Genome Sciences Inc., a GSK Company | 1 |
| NephroGenex, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Diseases | 22 |
| Renal Insufficiency, Chronic | 8 |
| Diabetes Mellitus, Type 2 | 4 |
| Glomerulonephritis | 4 |
| Urologic Diseases | 4 |
| Diabetic Nephropathies | 3 |
| Glomerulonephritis, IGA | 3 |
| Carcinoma, Renal Cell | 2 |
| Heart Diseases | 2 |
| Kidney Failure, Chronic | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.